Dr. Chandana Mareddy

• MBBS, MD Paediatrics, FIAP (PHO), MTIp (UK), PHO, BMT

After formal paediatric training, Dr Chandana has entered Senior residency in Niloufer Hospital, Osmania. She further pursued fellowship in Paediatric Haematology and Oncology from Sir Gangaram Hospital, New Delhi from Indian Academy of Paediatrics, PHO Chapter. She gained immense clinical skills during that time. She later continued her practice at Apollo Cancer Centre, Hyderabad as Junior Consultant handling complex cases alongside adult counter parts. She later pursued Clinical Fellowship in the same field at Great Ormand Street Hospital, London, UK where she got to involve in new and cutting edge treatment modalities being practiced in United Kingdom like front line immunotherapies, CART cell therapy and observing many research phase 1, 2 trials both in haematology and oncology domains..

• Haematology
• Benign Haematology
• Sickle Cell Disease
• Thalassemia
• Leukemias
• Histiocytic Disorders
• Congenital Haematological Disorders.

• Oncology
• Lymphomas
• Wilms tumour
• Neuroblastoma
• Sarcomas
• Bone tumours
• Liver tumours
• Brain tumours
• Immunotherapies; BMT/ CART

• Generic Romiplostim in children with persistent or chronic ITP – experience from tertiary care centre in North India published in British Journal of Haematology.
• Clinical significance of pro calcitonin in lower respiratory tract infections in children ( 6 months to 6 years ) under Dr Devraj and Dr Arif Ahmed, Shadan institute of medical sciences, Hyderabad.
• Investigator in COVAXIN vaccine trial by Bharath biotech against SARS COV2.
• Author for Sickle Cell Disease training modules, approved by Ministry Of Health and tribal affairs.

• IAP, Paediatrics India membership no: AL1207/C-212
• IAP PHO ( Lifetime member ): L/2024/1206
• SIOP